Skip to main content
Our Work

Envisioning a Transformed Clinical Trials Enterprise for 2030 - A Workshop

Completed

Topics

This 4-part virtual public workshop provided a venue for stakeholders to consider a transformed clinical trials enterprise for 2030. Workshop participants considered lessons learned from progress and setbacks over the past 10 years, since the previous workshop, Envisioning a Transformed Clinical Trials Enterprise in the United States, and, looking forward, discussed goals and key priorities for advancing a clinical trials enterprise that is more efficient, effective, patient-centered, and integrated into the health delivery system of 2030. The workshop was hosted by the National Academies Forum on Drug Discovery, Development, and Translation.

Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.